↓ Skip to main content

Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, December 2020
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
57 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
Published in
Journal of Hematology & Oncology, December 2020
DOI 10.1186/s13045-020-01009-7
Pubmed ID
Authors

Yulong Fu, Yang Zhang, Zhe Lei, Ting Liu, Tingting Cai, Anqi Wang, Wenwen Du, Yuanyuan Zeng, Jianjie Zhu, Zeyi Liu, Jian-an Huang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 34 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 15%
Other 3 9%
Student > Bachelor 3 9%
Professor 1 3%
Student > Ph. D. Student 1 3%
Other 1 3%
Unknown 20 59%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 24%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Medicine and Dentistry 3 9%
Sports and Recreations 1 3%
Arts and Humanities 1 3%
Other 0 0%
Unknown 18 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 June 2022.
All research outputs
#18,111,817
of 23,269,984 outputs
Outputs from Journal of Hematology & Oncology
#886
of 1,207 outputs
Outputs of similar age
#359,100
of 508,622 outputs
Outputs of similar age from Journal of Hematology & Oncology
#38
of 47 outputs
Altmetric has tracked 23,269,984 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 508,622 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.